Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Giovanni Rocchi"'
Publikováno v:
Journal of Infectious Diseases. 128:283-289
Sera from healthy donors and individuals with primary Epstein-Barr virus (EBV) infections were titrated for EBV-neutralizing antibodies, and the results were compared with those obtained in indirect immunofluorescence assays for antibodies to EB-vira
Publikováno v:
Journal of Medical Virology. 6:203-211
The antibody reactive in antibody-dependent, cell-mediated cytotoxicity (ADCC) to influenza virus-infected cells was measured in two groups of seven volunteers each, before and after immunization with inactivated or live attenuated A/Victoria/3/75 in
Autor:
G. Ragona, C. Piga, A. De Felici, A. Pelosio, N. Legniti, Stefano Vella, Antonio Volpi, Giovanni Rocchi
Publikováno v:
Journal of Hygiene. 83:383-390
Immunization procedures with live attenuated and inactivated vaccines were carried out on a group of young recruits at the beginning of an outbreak of infection due to an A/Victoria/3/75-related virus strain, which occurred in February 1977 in a mili
Publikováno v:
JNCI: Journal of the National Cancer Institute. 50:307-314
Autor:
Peter Gunvén, Surjit Singh, Werner Henle, Aberra Demissie, John F. Hewetson, Gertrude Henle, Peter Clifford, Angel Guerra, George Klein, Arne Svedmyr, Giovanni Rocchi
Publikováno v:
International Journal of Cancer. 12:115-123
Antibodies against several EBV- and non-EBV-associated antigens were titrated in serial sera from a patient with Burkitt's lymphoma who was given immune stimulants during chemotherapeutically induced tumor regression. EBV-associated membrane reactive
Publikováno v:
New England Journal of Medicine. 296:132-134
We devised a quantitative assay for Epstein-Barr-virus-infected mononuclear leukocytes (virocytes) to determine their prevalence in the blood of patients with acute-phase and convalescent-phase infectious mononucleosis and in healthy Epstein-Barr-vir
Publikováno v:
International journal of cancer. 11(3)
The results of Epstein-Barr virus (EBV) neutralization tests on 650 sera from patients with EBV-associated diseases and controls were compared with the titers of antibodies to EB viral capsid antigens (anti-VCA) and to EBV-induced early antigens (ant